Target intelligence / Profile preview

Other autoinducer-2 receptor

Molecular classification
Receptor, Histidine kinase, Transporter, Chemoreceptor, Transcription factor
01

Overview

Other autoinducer-2 receptor refers to a diverse group of bacterial proteins that recognize the universal quorum-sensing signal autoinducer-2 (AI-2), distinct from the well-characterized LuxP and LsrB families (Source: NIH, Frontiers in Microbiology). These receptors include the ribose-binding protein RbsB, the histidine kinase AsrK, and various chemoreceptors such as PctA and TlpQ, which allow a wide range of bacteria to sense and respond to interspecies communication (Source: NIH, ACS Chemical Biology). AI-2 is a byproduct of the activated methyl cycle, and its perception by these receptors regulates critical processes such as biofilm formation, motility, and the expression of virulence factors (Source: NIH, Journal of Bacteriology). Because AI-2 signaling is central to bacterial coordination and pathogenesis, these receptors are attractive targets for pathoblocker or anti-virulence therapies (Source: NIH, MDPI). Small molecule inhibitors, often structural analogs of the AI-2 precursor DPD, can competitively bind to these receptors to disrupt quorum sensing without killing the bacteria, potentially reducing the selective pressure for antibiotic resistance (Source: ACS Chemical Biology). However, the high conservation of binding domains among different sugar-binding proteins and the potential for disrupting beneficial commensal bacteria present significant therapeutic challenges (Source: NIH, Nature Communications).

Other names
Non-canonical autoinducer-2 receptorAlternative AI-2 binding proteinNon-LuxP/Non-LsrB AI-2 receptorRbsB (Ribose-binding protein)AsrK (Histidine kinase)PctA (Chemoreceptor)TlpQ (Chemoreceptor)KinD (Histidine kinase)MapR (Methyl-accepting chemotaxis protein)LsrR (Intracellular AI-2 regulator)
02

Mechanism of action

Quorum sensing inhibition via competitive antagonism of AI-2 binding sites or modulation of downstream signal transduction pathways, thereby preventing the activation of virulence and biofilm-related genes.

03

Biological functions

Quorum sensingSignal transductionChemotaxisBiofilm formationVirulence factor regulation
04

Disease associations

Infection
05

Safety considerations

Disruption of host commensal microbiotaTarget specificity and cross-reactivity with host sugar-binding proteinsDevelopment of non-lethal resistance mechanisms
06

Interacting drugs

Autoinducer-2 analogs

5 more in the full profile.

07

Biomarkers

Extracellular autoinducer-2 (AI-2) concentrationBiofilm formation indexVirulence gene expression levels (e.g., luxS, lsrB)Bioluminescence in reporter strains

Beyond the preview

Go deeper on Other autoinducer-2 receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Other autoinducer-2 receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call